- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Teva Investigational Site 165 Tucson, Arizona, United States
- Teva Investigational Site 167 Little Rock, Arkansas, United States
- Teva Investigational Site 11 Corona, California, United States
- Teva Investigational Site 21 Fountain Valley, California, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
3,651 public trials
849 recruiting studies
Lymphoma trial results
NCT00445952
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +116 more
- Locations
-
- Institut Jules Bordet Brussels, Belgium
- CHU de Grenoble - Hopital de la Tronche Grenoble, France
- German Hodgkin's Lymphoma Study Group Cologne, Germany
- Ospedale San Martino Genoa, Italy
Completed
A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers
NCT01460134
- Conditions
- Adenocarcinoma, Adnexal Diseases, Any T-cell Malignancy, +70 more
- Locations
-
- Mayo Clinic Arizona - Cancer Clinical Research Unit Scottsdale, Arizona, United States
- Stanford Cancer Center - Stanford University Stanford, California, United States
- Mayo Clinic Rochester, Minnesota, United States
- Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine New York, United States
NCT02219737
- Conditions
- CD20 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Completed
SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients
NCT01472887
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Investigational Site Number 840001 Denver, Colorado, United States
- Investigational Site Number 840003 Augusta, Georgia, United States
- Investigational Site Number 840005 Boise, Idaho, United States
- Investigational Site Number 056002 Ghent, Belgium
NCT02142530
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B-cell Lymphoma, +27 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Conditions
- Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Buenos Aires, Argentina
- Corrientes, Argentina
- Santa Fe, Argentina
- Canberra, Australian Capital Territory, Australia
NCT01097057
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01646021
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Antwerp, Belgium
- Bruges, Belgium
- Brussels, Belgium
- Edegem, Belgium
NCT00867529
- Conditions
- B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, +83 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States